Switching from Mounjaro to Wegovy means changing from tirzepatide to semaglutide. Questions about appetite, side effects and continuity of care are reasonable, but the two medicines are not interchangeable dose for dose. A prescriber needs to plan the change; a forum comparison cannot supply an individual switching schedule.

Mounjaro and Wegovy: different active ingredients

Tirzepatide acts at GIP and GLP-1 receptors; semaglutide acts at GLP-1 receptors. Mounjaro is not a mixture of two medicines: one active ingredient has dual receptor activity. The number of receptor targets alone cannot tell someone which medicine will be easier to tolerate.

Side effects when switching: what experiences can tell us

Community accounts describe different experiences of nausea, appetite and treatment changes. They can help identify questions to ask, but they do not establish that removing GIP activity will improve or worsen side effects. Reports may involve different doses, medical histories and reasons for switching.

  • Explain why a change is being considered: symptoms, access, cost or treatment goals.
  • Ask how the prescriber will review tolerability and ongoing support.
  • Keep the exact medicine and prescription details available for that discussion.

Scientific Context and Research Use

While early studies and regulatory data provide insights into the mechanisms of these medications, ongoing research is necessary to fully elucidate their comparative effects and tolerability. It is important to distinguish between anecdotal evidence and verified scientific findings when considering peptide-based therapies.

Research-use disclaimer: The information provided here is for educational purposes only and does not constitute medical advice or prescribing guidance. Mounjaro and Wegovy are prescription medicines with authorised uses; research-use catalogue products are a separate category and must not be substituted for them.

Related reading

Explore GLP-1 side effects, Wegovy treatment interruptions.

Sources

NHS: tirzepatide — https://www.nhs.uk/medicines/tirzepatide/

Wegovy UK product information — https://www.medicines.org.uk/emc/product/13801/smpc